Alnylam Pharmaceuticals, Inc. is 10% Owner at Regulus Therapeutics Inc. (RGLS). They have made 1 open-market trade across 1 company since 2014, most recently 2016-02-23.
CIK 0001178670
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGLS | SELL | 2016-02-23 | 2016-02-24 | $7.18 | $7.2M | +14.4% | -9.1% | -13.8% |
| RGLS | SELL · 10b5-1 | 2014-10-22 | 2014-10-28 | $14.02 | $1.6M | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-10-22 | 2014-10-24 | $14.02 | $1.6M | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-10-15 | 2014-10-17 | $6.74 | $81K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-10-08 | 2014-10-10 | $6.56 | $66K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-10-01 | 2014-10-03 | $6.74 | $69K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-09-24 | 2014-09-26 | $7.13 | $62K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-09-17 | 2014-09-19 | $7.31 | $56K | -29.3% | -0.2% | -0.2% |
| RGLS | SELL · 10b5-1 | 2014-09-10 | 2014-09-12 | $7.85 | $70K | -29.3% | -0.2% | -0.2% |
| "RGLS" | SELL · 10b5-1 | 2014-08-27 | 2014-08-29 | $7.00 | $35K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-08-20 | 2014-08-22 | $6.89 | $74K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-08-13 | 2014-08-15 | $7.02 | $38K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-08-06 | 2014-08-08 | $6.87 | $52K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-07-30 | 2014-08-01 | $6.35 | $34K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-07-23 | 2014-07-25 | $6.75 | $35K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-07-16 | 2014-07-18 | $6.66 | $90K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-07-09 | 2014-07-11 | $6.73 | $54K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-07-02 | 2014-07-07 | $8.07 | $35K | N/A | N/A | N/A |
| "RGLS" | SELL · 10b5-1 | 2014-06-25 | 2014-06-27 | $7.88 | $60K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.